Stock Research: COSMOS Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

COSMOS Pharmaceutical

TSE:3349 JP3298400007
42
  • Value
    60
  • Growth
    67
  • Safety
    Safety
    25
  • Combined
    49
  • Sentiment
    41
  • 360° View
    360° View
    42
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

COSMOS Pharmaceutical Corporation operates drug stores, offering medical goods, cosmetics, and general food products. In the last fiscal year, the company had a market cap of $4962 millions, profits of $1481 millions, and revenue of $7022 millions.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 42 (better than 42% compared with alternatives), overall professional sentiment and financial characteristics for the stock COSMOS Pharmaceutical are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for COSMOS Pharmaceutical. The consolidated Growth Rank has a good rank of 67, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 67% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 60 which means that the company has a financing structure that is safer than 60% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 25 which means that the share price of COSMOS Pharmaceutical is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 75% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 41, which means that professional investors are more pessimistic about the stock than for 59% of alternative investment opportunities. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
25 31 23 17
Growth
67 69 51 75
Safety
Safety
60 55 69 67
Sentiment
41 91 49 45
360° View
360° View
42 79 42 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
51 57 29 29
Opinions Change
18 62 39 50
Pro Holdings
n/a 83 67 49
Market Pulse
76 71 75 65
Sentiment
41 91 49 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
25 31 23 17
Growth
67 69 51 75
Safety Safety
60 55 69 67
Combined
49 50 37 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
39 41 27 29
Price vs. Earnings (P/E)
47 48 43 38
Price vs. Book (P/B)
43 43 39 36
Dividend Yield
20 25 18 14
Value
25 31 23 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
65 70 70 65
Profit Growth
37 69 26 21
Capital Growth
78 48 44 55
Stock Returns
49 29 67 71
Growth
67 69 51 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
70 75 82 86
Refinancing
24 11 24 24
Liquidity
79 79 90 90
Safety Safety
60 55 69 67

Similar Stocks

Discover high‑ranked alternatives to COSMOS Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Daiwabo Holdings

TSE:3107
Country: Japan
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Isuzu Motors

TSE:7202
Country: Japan
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Canon Marketing Japan

TSE:8060
Country: Japan
Industry: Technology Distributors
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.